Oxypronal Lp (Oxycodone Hydrochloride, Naloxone Hydrochloride Dihydrate)

Oxycodone Hydrochloride, the active ingredient in Oxypronal Lp, is an opioid analgesic presented as an oral formulation for systemic use. It is combined with naloxone hydrochloride dihydrate to mitigate opioid‑induced constipation and is prescribed for moderate to severe pain in adult patients. GNH USA supplies Oxypronal Lp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxypronal Lp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxypronal Lp contains oxycodone, an opioid that acts on the central nervous system to relieve pain. It is indicated for: - Severe acute pain: provides rapid relief of intense pain following surgery or trauma. - Chronic cancer‑related pain: helps manage persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: used when other analgesics are insufficient for conditions such as severe osteoarthritis. - Pain during palliative care: improves comfort for patients with end‑of‑life pain. - Post‑operative pain: reduces pain intensity after major surgical procedures.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel movements. - Dizziness: feeling light‑headed or unsteady. - Somnolence: increased sleepiness. - Dry mouth: reduced salivation. - Pruritus: mild itching.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Opioid dependence or withdrawal: signs of addiction. - Hepatic dysfunction: abnormal liver enzyme levels. - Anaphylaxis: severe allergic reaction. - Seizures: rare convulsive episodes.

When prescribing Oxypronal Lp, clinicians should consider several safety measures.

- Assess pain severity and opioid tolerance before initiating therapy. - Monitor for signs of respiratory depression, especially in opioid‑naïve patients. - Evaluate liver and kidney function regularly, adjusting dose as needed. - Avoid concurrent use with other central nervous system depressants. - Counsel patients on the risk of dependence and proper disposal of unused tablets. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Oxypronal Lp can interact with a range of medicines, requiring careful management.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause profound respiratory depression. - CNS depressants: additive sedation and impaired cognition. - MAO inhibitors: may precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): increase oxycodin plasma levels. - CYP3A4 inducers (e.g., rifampicin): reduce analgesic effect. - Anticholinergic agents: may worsen constipation. - Diuretics: can enhance hypotensive effects. - Serotonergic antidepressants: risk of serotonin syndrome when combined with high opioid doses.